Stock ADDV A ADDVISE GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings ADDvise Group AB

Equities

ADDV A

SE0001306119

Market Closed - Nasdaq Stockholm
Other stock markets
 09:07:01 2024-05-23 am EDT 		5-day change 1st Jan Change
14.3 SEK -0.35% Intraday chart for ADDvise Group AB -1.38% -17.58%
May. 03 ADDvise Group AB Announces Board Appointments CI
May. 02 Addvise Group AB Announces Chief Executive Officer Changes CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation
  • The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ADDVISE GROUP AB Stock ADDvise Group AB
-17.58% 138M
D+
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.31% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-1.21% 108B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.53% 66.57B
A
DEXCOM, INC. Stock DexCom, Inc.
+1.22% 49.95B
B-
CENCORA, INC. Stock Cencora, Inc.
+7.03% 43.84B
B-
HOYA CORPORATION Stock Hoya Corporation
+5.25% 41.71B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+21.96% 31.59B
B
TERUMO CORPORATION Stock Terumo Corporation
+14.11% 25.3B
A-
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-4.81% 23.83B
B
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
  1. Stock Market
  2. Equities
  3. ADDV A Stock
  4. Ratings ADDvise Group AB